Form 8-K TG THERAPEUTICS, INC. For: Aug 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
TG Therapeutics (TGTX) PT Raised to $30 at JPMorgan
August 7, 2024 6:17 AM EDTJPMorgan analyst Eric Joseph raised the price target on TG Therapeutics (NASDAQ: TGTX) to $30.00 (from $26.00) while maintaining a Overweight rating.
The analyst comments "Following TGs 2Q results and conference call we are updating our model, with takeaways from the call... More
